California Stem Cell Agency Backs Away from Covid Vaccine Plan; Concerns Raised About Mission Creep
Directors of the $3 billion California stem cell agency have rejected a Covid-19 proposal to extend the agency's reach beyond stem cells, expressing concerns about mission creep, public relations and dilution of cash for other important research.
The case in point last Friday was "emergency" consideration of a plan to fund Covid-19 vaccine development as…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.